Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of CCM2L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 650.10 | 652 / 653 | 96% | 4.47 | 581 / 605 |
| adrenal gland | 99% | 279.44 | 255 / 258 | 94% | 4.75 | 217 / 230 |
| brain | 96% | 222.61 | 2533 / 2642 | 97% | 2.79 | 686 / 705 |
| breast | 100% | 881.74 | 458 / 459 | 90% | 2.64 | 1009 / 1118 |
| prostate | 98% | 353.22 | 240 / 245 | 85% | 1.93 | 427 / 502 |
| kidney | 99% | 461.65 | 88 / 89 | 78% | 6.09 | 704 / 901 |
| lung | 99% | 720.29 | 570 / 578 | 67% | 1.62 | 778 / 1155 |
| bladder | 100% | 377.14 | 21 / 21 | 59% | 1.24 | 299 / 504 |
| ovary | 73% | 182.99 | 131 / 180 | 85% | 2.53 | 366 / 430 |
| stomach | 90% | 189.58 | 322 / 359 | 67% | 2.00 | 192 / 286 |
| uterus | 100% | 630.76 | 170 / 170 | 52% | 1.38 | 238 / 459 |
| intestine | 96% | 263.64 | 931 / 966 | 55% | 1.10 | 291 / 527 |
| esophagus | 93% | 302.74 | 1347 / 1445 | 55% | 1.20 | 101 / 183 |
| pancreas | 38% | 50.86 | 126 / 328 | 87% | 2.37 | 155 / 178 |
| skin | 63% | 142.42 | 1146 / 1809 | 47% | 0.92 | 223 / 472 |
| liver | 26% | 35.28 | 58 / 226 | 78% | 1.68 | 317 / 406 |
| spleen | 100% | 7503.36 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 902.71 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 485.42 | 848 / 861 | 0% | 0 | 0 / 0 |
| muscle | 89% | 157.54 | 711 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 74% | 206.48 | 986 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 1.03 | 16 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 0.78 | 22 / 45 |
| eye | 0% | 0 | 0 / 0 | 19% | 0.26 | 15 / 80 |
| peripheral blood | 1% | 1.75 | 10 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008150 | Biological process | biological_process |
| GO_0003007 | Biological process | heart morphogenesis |
| GO_0005575 | Cellular component | cellular_component |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | CCM2L |
| Protein name | Cerebral cavernous malformations 2 protein-like (CCM2-like) |
| Synonyms | C20orf160 |
| Description | |
| Accessions | Q9NUG4 ENST00000262659.12 [Q9NUG4-2] ENST00000452892.3 [Q9NUG4-1] |